Literature DB >> 11197830

Hypertrophic obstructive cardiomyopathy associated with mitral regurgitation due to infective endocarditis.

M Ninomiya1, S Takamoto, Y Kotsuka, T Ohtsuka, K Ueno.   

Abstract

A 25-year-old woman treated for hypertrophic obstructive cardiomyopathy and suffering from mitral regurgitation due to infective endocarditis was referred to our department for surgery. Preoperative examinations revealed asymmetric septal hypertrophy, a large left ventricular outflow gradient (100 mmHg), and perforation of the anterior mitral leaflet resulting in severe mitral regurgitation. The entire mitral complex was resected and septal myectomy conducted to dilate the left ventricle. A bioprosthetic valve was then implanted. Although postoperative heart failure was severe, cardiac function has gradually recovered. The left ventricular outflow gradient has decreased to 8 mmHg, the diastolic left ventricular diameter has increased from 26 to 30 mm, and her New York Heart Association classification has improved from IV to I.

Entities:  

Mesh:

Year:  2000        PMID: 11197830     DOI: 10.1007/bf03218260

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  7 in total

1.  TRANSATRIAL EXPOSURE FOR CORRECTION OF SUBAORTIC STENOSIS.

Authors:  C W LILLEHEI; M J LEVY
Journal:  JAMA       Date:  1963-10-05       Impact factor: 56.272

2.  Transatrial and transmitral approach for left ventricular myectomy and mitral valve plication for diffuse-type hypertrophic obstructive cardiomyopathy: a novel approach.

Authors:  H Matsuda; F Nomura; K Kadoba; K Taniguchi; H Imagawa; K Kagisaki; T Sano
Journal:  J Thorac Cardiovasc Surg       Date:  1996-07       Impact factor: 5.209

3.  Comparison of ventricular septal surgery and mitral valve replacement for hypertrophic obstructive cardiomyopathy.

Authors:  W S Walker; K G Reid; E W Cameron; P R Walbaum; A H Kitchin
Journal:  Ann Thorac Surg       Date:  1989-10       Impact factor: 4.330

4.  Septal myotomy-myomectomy versus mitral valve replacement in hypertrophic cardiomyopathy. Ten-year follow-up in 185 patients.

Authors:  Z Krajcer; R D Leachman; D A Cooley; R Coronado
Journal:  Circulation       Date:  1989-09       Impact factor: 29.690

5.  Septal myomectomy and mitral valve replacement for idiopathic hypertrophic subaortic stenosis: short- and long-term follow-up.

Authors:  S Fighali; Z Krajcer; R D Leachman
Journal:  J Am Coll Cardiol       Date:  1984-05       Impact factor: 24.094

Review 6.  Hypertrophic obstructive cardiomyopathy and infective endocarditis: a report of seven cases and a review of the literature.

Authors:  N Alessandri; G Pannarale; F del Monte; F Moretti; B Marino; A Reale
Journal:  Eur Heart J       Date:  1990-11       Impact factor: 29.983

7.  Results of surgery for hypertrophic obstructive cardiomyopathy.

Authors:  W G Williams; E D Wigle; H Rakowski; J Smallhorn; J LeBlanc; G A Trusler
Journal:  Circulation       Date:  1987-11       Impact factor: 29.690

  7 in total
  1 in total

Review 1.  Mitral valve endocarditis in hypertrophic cardiomyopathy: case report and literature review.

Authors:  G Morgan-Hughes; J Motwani
Journal:  Heart       Date:  2002-06       Impact factor: 5.994

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.